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Abstract
Background: IL-2 receptor (IL2R) alpha is the specific component of the high affinity IL2R system involved in the immune
response and in the control of autoimmunity.
Methods and Results: Here we perform a replication and fine mapping of the IL2RA gene region analyzing 3 SNPs
previously associated with multiple sclerosis (MS) and 5 SNPs associated with type 1 diabetes (T1D) in a collection of 798 MS
patients and 927 matched Caucasian controls from the south of Spain. We observed association with MS in 6 of 8 SNPs. The
rs1570538, at the 39- UTR extreme of the gene, previously reported to have a weak association with MS, is replicated here
(P=0.032). The most associated T1D SNP (rs41295061) was not associated with MS in the present study. However, the
rs35285258, belonging to another independent group of SNPs associated with T1D, showed the maximal association in this
study but different risk allele. We replicated the association of only one (rs2104286) of the two IL2RA SNPs identified in the
recently performed genome-wide association study of MS.
Conclusions: These findings confirm and extend the association of this gene with MS and reveal a genetic heterogeneity of
the associated polymorphisms and risk alleles between MS and T1D suggesting different immunopathological roles of IL2RA
in these two diseases.
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Introduction
Multiple sclerosis (MS) is the most common central nervous
system disease in young adults, and one of the leading causes of
disability in this age group affecting over 2.5 million individuals
world-wide [1] The prevalence and incidence rates in Spain are
around 77/100 000 habitants and 5.3/100 000 habitants per year
respectively similar to what has been found in Britain [2,3] The
disorder, which is presumed to be autoimmune in nature, is
characterized by inflammation and demyelination, with axonal
and neuronal degeneration. Susceptibility to MS is thought to be
conferred by the combination of many common gene variants (not
aberrant gene products) and environmental factors, which are
mostly unknown [1,4].
The most strongly associated region implicated in predisposition
to MS is the major histocompatibility complex (MHC) on
chromosome 6p21, specifically the HLA-DRB1* 1501 class II
allele; but, this account for less than 50% of MS genetics [1,5].
Recently, other regions have been implicated in MS susceptibility
and replicated in different independent populations as the
interleukin 7 receptor alpha (IL7RA) [6–8], the interferon
regulatory factor 5 (IRF5) gene [9] and the interleukin-2 receptor
alpha (IL2RA) [8,10,11]. The IL2RA gene has also been associated
with type 1 diabetes (T1D) [12–14] and localized the association
region in two independent groups of SNPs, spanning overlapping
regions of 14 and 40 Kb encompassing IL2RA intron 1 and the 59
regions of IL2RA and the RNA binding motif protein 17 (RBM17)
genes.
Diverse autoimmune diseases may coexist in the same
individual and in families, suggesting they might share common
susceptibility gene variants implying a common etiology [15,16].
For example, in families with systemic lupus erythematosus (SLE),
other autoimmune mediated diseases, such as MS and rheumatoid
arthritis (RA) [17], or families with T1D and MS in Sardinian
population [18], occur more frequently than in the general
population. Such observations and others suggest the existence of
shared genes or involvement of common biochemical pathways in
these diseases. This hypothesis is supported by numbers of reports
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disease, for example the Protein Tyrosine Phosphatase Nonre-
ceptor 22 (PTPN22) has been associated with T1D [19], RA [20],
and SLE [21], the IRF5 with SLE [22], inflammatory bowel
diseases [23], RA [24] and MS [9], the FCRL3 with RA,
autoimmune thyroid disease, SLE [25] and MS [26], among
several other examples. However, population-based studies of
.30 000 MS first-degree relatives found no increase in autoim-
mune disease [27].
As the associated SNPs analyzed in a genome wide association
scan (GWAS) [8], candidate-gene association study in MS [10]
and T1D [13] were not the same [28] we considered interesting to
test if the TID-associated SNPs in the IL2RA region [13] were also
associated with multiple sclerosis (MS) in our cohort of MS
patients. In addition, we confirmed one of the two polymorphisms
that have been associated with MS in the GWAS [8] and the one
associated with MS in our previous candidate-gene association
study of IL2RA gene [10].
Methods
Study subjects
Case samples comprised 798 patients with clinically defined MS
according to Poser’s criteria [29] They were obtained from four
public hospitals: the Hospital Clı ´nico in Granada (n=130), the
Hospital Virgen de las Nieves de Granada (n=153), the Hospital
Carlos Haya in Ma ´laga (n=357) and the Hospital Virgen de la
Macarena in Seville (n=158) all three cities within a 200 km
radius in the South of Spain. The mean age at the sample
collection of the cases was 36 years and mean age of controls at
interview was 38 years. The percentage of females was 68% for
cases and 59% for controls. All of them were classified as RR
(relapsing-remitting) or SP (secondary progressive) MS cases.
Controls were 927 blood donors with no history of inflammatory
disease attending the blood banks of Granada (n=619), Seville
(n=138) and Ma ´laga (n=170). The study was approved by the
Ethics Committees of each of the hospitals participating in the
study and written informed consent was obtained from all
participants.
Genotyping
The SNPs were selected for being associated with MS
(rs1570538, rs2104286, rs12722489) [8,10] or with T1D
(rs10795791, rs4147359, rs7090530, rs41295061, rs35285258)
[13] in previous studies.
High-molecular-weight DNA was isolated from whole blood
using the Flexigene Kit (Qiagen, Hildren, Gemany) according to
the manufacturer’s protocol. We studied 8 SNPs located in the
IL2RA locus as has been indicated in Fig. 1. rs1570538 was
genotyped by restriction fragment length polymorphism method
Primer sequences used were as follows: forward, TCATGTGA-
CATCTGGAGGGTTA and reverse, AAAATGAATTTCGT-
CAATTCGAG, restriction enzyme MwoI. The rest of the SNPs
were genotyped by TaqMan technology under conditions
recommended by the manufacturer (Applied Biosystems, Foster
City, CA, USA). A total of 10 negative controls and 8 duplicates
were included for each SNP as a quality control measure.
Statistical Analysis
The statistical studies to compare allelic and genotypic
distribution between patients and controls were performed by
Pearson x
2 test or Fisher’s exact test on 262 and 263 contingency
tables, respectively, using the package available from the web of
the Institute of Human Genetics of the Technical University of
Munich (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl) and the SPSS
15.0 statistical package. Hardy Weinberg equilibrium was tested
using x
2 goodness-of-fit test and no significant deviation was
observed for any of the SNPs in this study (all P.0.05). Logistic
regression analysis was used to calculate odds ratios (ORs) and
95% Confidence Intervals (C.I.s) for genotypes. To evaluate
whether the best model is statistically significant, a permutation
test was applied to obtain a p-value. The Haploview v.3.3 software
[30] was used to generate haplotypes, perform haplotype
association analysis, and to determine linkage disequilibrium
(LD) measures (r
2) between the polymorphisms. P-values reported
are unadjusted except for the most associated SNPs in whose case
they were corrected for multiple testing assuming 8 independent
SNP markers.
Assuming a minor allele frequency between 6.8–48.4% and a
0.05% prevalence of MS in the Spanish population, we estimated
that at the 5% significance level, this study had between 44–92%
power to detect genotypic relative risks reported in the first
association study. The power that we had to detect effects was
actually lower than in the original MS and T1D studies where
larger cohorts were used (Table 1).
Results
Eight polymorphisms in the IL2RA gene were genotyped in 798
MS patient samples and 927 sex-matched Caucasian controls from
the south of Spain. The linkage disequilibrium (LD) and their
precise localization in the chromosome are indicated in the Fig. 1.
The rs1570538 is located at the 39-untranslated region (39- UTR)
of IL2RA [10], rs2104286 and rs12722489 are located at the 59-
proximal intron 1 region of the IL2RA [8], and the SNPs
rs10795791, rs4147359, rs7090530, rs41295061 and rs35285258
are located at the 59-upstream region of the IL2RA, in the
intergenic region between IL2RA and RBM17 genes [13].
We found the additive effect of allele dosage as the most
plausible genetic model for rs2104286, rs7090530 and
rs35285258. The recessive model seemed to fit better for
rs1570538 (Table S1). The best model for all the other SNPs
was also the additive one among the four tried: additive effect of
allele dosage (allelic tests), recessive action, dominant action,
additive+dominant (genotypic tests). Thus, we used the additive
dosage model although in those SNPs there was not statistically
significant support for the chosen model to be the best.
Six out of eight polymorphisms exhibited allelic association with
MS, with nominal P-values ranging from 0.0016 to 0.033 (Table 1).
All of them also showed significant association when genotypes
instead of alleles and the Cochran-Armitage trend test where used
(P values from 0.0016 to 0.033, Table S2). The Cochran-Armitage
trend test has better power for near-additive risks models [31] than
the Fisher exact test.
rs1570538 has been shown to be weakly associated with
multiple sclerosis in our previous study of IL2RA/MS in a cohort
of 346 cases and 413 controls (allelic P-value=0.04) [10] and
showed here increased statistical significance with our actual
extended cohort (allelic association P=0.033; OR for minor
allele=0.86, 95% CI, 0.75–0.99; genotype association (Cochran-
Armitage trend test P=0.033). We did not find any statistically
significant evidence for MS association with either rs41295061 nor
for rs12722489 by using the Cochran-Armitage trend test
(P=0.279 and P=0.133 for rs12722489 and rs41295061
respectively) or the Fisher exact test in genotypes (P=0.501 and
P=0.243 for rs12722489 and rs41295061 respectively) and alleles
(P=0.278 and P=0.135 for SNPs rs12722489 and rs41295061
respectively). The strongest association signals in this study were
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genotype association, survived after correction for multiple tests by
Bonferroni (Table S2). For the rs7090530, the data revealed a
significant over-representation of the C allele among cases
compared with controls (OR=1.23, 95% C.I.=1.07–1.41,
P=0.003). Very similar data were obtained for the T allele of
rs35285258 (OR=1.26, 95% C.I.=1.09–1.46, P=0.0016).
As observed in Fig. 1, rs7090530 and rs35285258 are in high
LD with a pairwise r
2=0,53. rs1570538, rs2104286, rs10795791
and rs4147359, are in partial LD ranging from 0.29 to 0.09 with
rs35285258. rs12722489 and rs41295061, negative for association
with MS in this study, were in very low LD with rs35285258
(r
2=0.06 and 0.033, respectively). Conditioned to rs35285258,
rs7090530 did not add any significant association, neither did the
other SNPs (P-values 0.2377, 0.1718, 0.5885, 0.3112, 0.4517,
0.2342 and 0.3116 for the seven SNPs respectively). Thus, the
rs7090530 association with MS could be explained by its strong
LD with rs35285258.
Discussion
The aim of this study was to determine whether there is a
common origin of the association of certain polymorphisms in the
region of the IL2RA gene in MS and T1D. The fine mapping of
the IL2RA region in T1D has located two ancestrally distinct
causal alleles that are marked by two independent groups of SNPs
at the first intron and the 59 region of the IL2RA gene [13]. The
genome wide association study of MS showed association with two
SNPs (rs2104286 and rs12722489) [8] located at the 59 region of
IL2RA [10], that were not in linkage disequilibrium with those
most associated with T1D [13]. The 39 UTR polymorphism,
rs1570538, which has been shown to be weakly associated with
MS in our previous study [13] is replicated here in a larger cohort
showing increased statistical significance. This could be due to the
LD that keeps with rs35285258 (r
2 0.11) and shows a haplotype-
specific effect.
The analysis of polymorphisms in this study reflects the
existence of a heterogeneous association between T1D and MS
that suggest different immunopathological mechanisms. It is
notable that rs41295061, the most associated with T1D [13],
was not associated with MS in this study.
rs35285258, belonging to the other independent group of SNPs
associated with T1D [13] showed the maximal association in this
study. However, the rs35285258 risk allele is C in the T1D study
[13] while it was T in our analysis of MS. This is also the case for
the rs4147359 and rs7090530 whose risk alleles were the contrary
to those observed for T1D [13]. This type of observation has also
been described for the FCRL-3 gene, encoding a member of the Fc
receptor-like family, specifically the C allele of FCRL3_3 variant
has been associated with susceptibility to several autoimmune
diseases [26] but showed to be protective for MS [27,28], and
Addison’s disease [32].
We replicated the association of only one (rs2104286) of the two
SNPs identified in the GWA study of MS [8]. Moreover SNPs
Figure 1. Schematic illustration of IL2RA locus showing the positions of the polymorphisms based on the NCBI Bild 35 and the
linkage disequilibrium (LD) structure of the IL2RA gene as pairwise r
2-values. The rs41295061 and the rs35285258 in this study correspond
to ss52580101 and ss52580135, respectively in the T1D study.
13 rs35285258 is in complete LD with rs11594656 (r
2=1) from the T1D study.
13 Both ss
(submitted snp) numbers can be found as rs (reference snp) numbers in the SNPdb of NCBI.
doi:10.1371/journal.pone.0004137.g001
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MS, have lower levels of statistical significance than SNPs
rs10795791, rs4147359, rs7090530, and rs35285258 from the
T1D study when typed in MS. This may be due to that the MS
associated SNPs come from a non exhaustive study of the locus
and they capture the causal SNP with low LD.
It is unknown whether there is any causal polymorphism in the
SNPs analyzed here and whether it can affect the level of
expression of the IL2RA product because none of these
polymorphisms are located in known regulatory regions.
rs4147359 G allele and the T allele of rs10795791 create a
putative recognition site for GATA-1 and GATA-2 transcription
factors, respectively. Although these two SNPs did not survive the
Bonferroni correction and had no effect conditioned on
rs35285258, they showed a significant haplotype-specific effect
(data not shown). The A allele of rs7090530 disrupted a putative
CpG dinucleotide, as it does the SNP rs11597367 described in the
T1D study [13], located at the 59 region of the IL2RA at position
6147540 and in total LD (r
2=1) with rs35285258. Methylation of
the CpG dinucleotides could be important for gene transcription
regulation as it has been demonstrated for the IL2 gene [33]
The T1D-risk alleles have been associated with reduced soluble
IL2R alpha concentrations. Thus, as the MS susceptibility alleles
correspond with the contrary ones to those associated in the T1D
study, we assume that the MS risk alleles might be associated with
the high concentration phenotype of soluble IL2RA protein.
Several aspects of the immune response could also be affected in
an opposite fashion to those in the T1D study, for instance, the
activity and functioning of activated Th1 and T regulatory cells
(CD4+CD25+) but at the moment, the relevance and the role of
this potential phenotypic data in the pathogenesis of MS is
unknown.
In summary, our results replicate and extend the association
found in the IL2RA gene region with MS and reveal differences in
the polymorphisms and risk alleles associated with T1D which
may reflect distinct roles that such gene variants may have in these
two pathologies.
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Table 1. Allele distribution and frequency of IL2RA SNPs in patients with multiple sclerosis and healthy controls.
SNP Alleles, n (%) OR minor allele [95% CI] P-value
Cases Controls This work
a GWAS/MS
b T1D
c
rs1570538
d C 734 (47.8) 851 (51.6) 0.86 [0.75–0.99] 0.033/0.04
d
SNP1 T 802 (52.2) 799 (48.4)
rs2104286 T 1237 (82.3) 1426 (79.1) 0.81 [0.68–0.96] 0.017 2.16610
27
SNP2 C 265 (17.7) 378 (20.9)
rs12722489 G 1216 (88.6) 1186(87.2) 0.87 [0.69–1.10] 0.278 2.96610
28 0.52
SNP3 A 156 (11.4) 1742(12.7)
rs10795791 A 933 (64.4) 1094 (60.6) 0.85 [0.74–0.98] 0.027 1.4610
26
SNP4 G 515 (35.6) 710 (39.4)
rs4147359 G 1105 (72.6) 1228 (69.0) 0.84 [0.72–0.98] 0.023 1.7610
25
SNP5 A 417 (27.4) 552 (31.0)
rs7090530
e A 741 (48.9) 996 (54.2) 1.23 [1.07–1.41] 0.003 3.6610
210
SNP6 C 767 (51.0) 840 (45.8)
rs41295061
f C 1436 (94.5) 1605 (93.2) 0.80 [0.60–1.07] 0.135 2.8610
212
SNP7 A 84 (5.5) 117 (6.8)
rs35285258
e, g C 921 (62.4) 1193 (67.7) 1.26 [1.09–1.46] 0.0016 5.3610
24
SNP8 T 555 (37.6) 569 (32.3)
aP-values=Pearson’s goodness-of-fit chi-square (df=1).
bGWAS/MS combined analysis including 1540 family trios, 2322 case subjects, and 5418 control subjects.
8
cT1D study from 2965 cases and 2548 controls [13].
dData from our previous work [10]. IL2RA/MS association study from 346 cases and 413 controls included in the present study.
ers7090530 and rs35285258 survived Bonferroni correction.
frs41295061 named ss52580101 in T1D study [13].
grs35285258 named ss52580135 in T1D study [13].
doi:10.1371/journal.pone.0004137.t001
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